About: Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 March 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в березні 2006 (uk) im März 2006 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en marzu de 2006 (ast) scientific article published on 01 March 2006 (en)
publication date	wds:Q82640069-2C543AAC-FE76-4E0A-814A-2F0591EA9624
publication date	2006-03-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q82640069-C46F20FB-7251-4D81-A2ED-74B37B6C9E92
language of work or name	English
cites work	wds:Q82640069-13A2D9CD-2C7F-4E82-ADDD-94897A82D784 wds:Q82640069-13A6A21C-DDC5-4C7D-BDFD-D833EB4539A8 wds:Q82640069-1979C5B1-D96D-48E2-91DC-005FEC12F24F wds:Q82640069-1BAD8D6F-5576-42F4-93CA-C86D7A728365 wds:Q82640069-25DBB230-433A-4FBD-A83D-DCB7A8B115CE wds:Q82640069-298F5F7B-0287-4D47-9BFF-DD318937ABA9 wds:Q82640069-4044FE8C-9A59-44AA-9115-1AD7C70670D4 wds:Q82640069-40DFC305-8E4C-49F8-BC25-A4E6D212C761 wds:Q82640069-458867FE-D596-46B2-BDF7-D39EE055EA6D wds:Q82640069-4DC5B40E-91C4-49F3-ABE3-F06CC0EA9BA5 wds:Q82640069-4F16D113-AD5E-41AB-964E-5AE4BCDC6C6D wds:Q82640069-51793A4A-9F01-4EA5-9389-65FE433B53DF wds:Q82640069-55B4EFD0-53BA-431E-B39C-A47647E49635 wds:Q82640069-58EFC46A-0EDB-4C3C-A3C3-BA3A19619EDE wds:Q82640069-5BB98B59-CDCF-4F7D-AD27-DCF7BD9FD84D wds:Q82640069-5BC0C2C4-6022-4024-9837-FDA11B27F4E3 wds:Q82640069-5DE37F62-E207-4BDA-9514-084A8C5EB573 wds:Q82640069-600E51A5-9DB6-46A4-9D1D-F511F8AFBE0D wds:Q82640069-60844C05-DE57-4A65-B24D-B8F0B5BBC879 wds:Q82640069-61FD4E99-6F05-45DF-B85F-ABB0E324CE27 wds:Q82640069-63B5E388-A112-4F3A-B6FF-1817DF5F6B40 wds:Q82640069-6614A5D9-3E5D-482D-9DE6-C87CACCBDF3A wds:Q82640069-6FCDE1C3-31F0-40B4-84A4-8B841D286C07 wds:Q82640069-78F82AF5-C6AC-4E4D-AB4B-23647560DA38 wds:Q82640069-7AFA5A42-40AC-4AD4-853E-9C4783AF6AE4 wds:Q82640069-8345474B-E54F-492D-9394-A1DC836F8FD8 wds:Q82640069-8DB91638-E6AB-4AC8-978E-5D24B10DD709 wds:Q82640069-A2839326-15C3-4BC7-B446-ACAB4DC1D890 wds:Q82640069-BB31B251-F2B9-4837-A1A5-1D71CBCB5720 wds:Q82640069-C14612CF-4533-466F-AA45-259A35AC36A0 wds:Q82640069-CDFB8676-7F6E-49EC-9296-66286184C6FD wds:Q82640069-CEBB382C-C600-4248-9AA1-5A45AE3B4526 wds:Q82640069-D71F8BB5-557A-4066-92C6-05EDA84C75F8 wds:Q82640069-DC2A7EFF-E727-43B4-92F2-690721E093A5 wds:Q82640069-DFE2D257-A381-4F0A-B94A-0C6FED808A6F wds:Q82640069-E1990854-9F2B-43E8-9C08-630A162002AB wds:Q82640069-E1A6F70E-E568-419D-BD75-CD9DCB477E1D wds:Q82640069-FC391289-E435-4A25-9F51-FA37EEB269EC
cites work	International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis The problem of chronic liver disease in young women Cytokine modulation by glucocorticoids: mechanisms and actions in cellular studies ACTIVE 'JUVENILE' CIRRHOSIS CONSIDERED AS PART OF A SYSTEMIC DISEASE AND THE EFFECT OF CORTICOSTEROID THERAPY Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared Autoantibodies in the Diagnosis and Management of Liver Disease The nature and prognostic implications of autoimmune hepatitis with an acute presentation Lupoid hepatitis Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis Genetic bases of autoimmune hepatitis. Hypothesis: The Aging Paradox and Autoimmune Disease Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Allelic sequence variation in the HLA class II genes and proteins in patients with autoimmune hepatitis Features reflective of early prognosis in corticosteroid-treated severe autoimmune chronic active hepatitis Significance of HLA DR4 in type 1 autoimmune hepatitis Diagnosis and treatment of autoimmune hepatitis Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis Adrenal cortical metabolism in chronic liver disease Genetic effects on susceptibility, clinical expression, and treatment outcome of type 1 autoimmune hepatitis Type I autoimmune hepatitis is primarily a disease of later life Understanding the pathogenesis of autoimmune hepatitis Treatment strategies in autoimmune hepatitis Autoimmune hepatitis in older patients. Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens. Autoimmune hepatitis in the elderly HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients Prognosis of corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis in postmenopausal women: a retrospective analysis Autoimmune chronic active hepatitis in postmenopausal women Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features Hepatitis and cirrhosis in women with positive clot tests for lupus erythematosus Progressive fibrosis during corticosteroid therapy of autoimmune hepatitis The relationship between autoimmune markers and different clinical syndromes in autoimmune hepatitis Protracted, but not acute, hepatitis A virus infection is strongly associated with HLA-DRB*1301, a marker for pediatric autoimmune hepatitis Chronic liver disease in young people. Clinical features and course in thirty-three patients Autoimmune hepatitis: Clinical manifestations and diagnostic criteria
author name string	wds:Q82640069-851F8F51-DB7B-428C-8FED-2491368312EE wds:Q82640069-DACF47C7-D9AE-464E-BFA5-A7CC1263FDA3
author name string	Albert J Czaja Herschel A Carpenter
rdfs:label	Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly (en) Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly (nl)
skos:prefLabel	Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly (en) Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly (nl)
name	Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly (en) Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly (nl)
title	wds:Q82640069-138DF61A-9837-4B10-ADEC-FB9EDD9A4DFC
title	Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly (en)
page(s)	wds:Q82640069-72EC62DB-779A-4861-9184-7D1FFB54ED8D
page(s)	532-538

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software